Barriers to early uptake of tetanus, diphtheria and acellular pertussis vaccine (Tdap) among adults—United States, 2005–2007
- 1 April 2011
- Vol. 29 (22) , 3850-3856
- https://doi.org/10.1016/j.vaccine.2011.03.058
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Effectiveness of Adolescent and Adult Tetanus, Reduced‐Dose Diphtheria, and Acellular Pertussis Vaccine against PertussisClinical Infectious Diseases, 2010
- Pertussis Disease Burden in the Household: How to Protect Young InfantsClinical Infectious Diseases, 2010
- Tetanus–diphtheria–acellular pertussis vaccination of adults in the USAExpert Review of Vaccines, 2008
- Adult pertussis vaccination strategies and their impact on pertussis in the United States: evaluation of routine and targeted (cocoon) strategiesEpidemiology and Infection, 2007
- Transmission of Bordetella pertussis to Young InfantsThe Pediatric Infectious Disease Journal, 2007
- A “New Age” in Pertussis Prevention: New Opportunities Through Adult VaccinationAmerican Journal of Preventive Medicine, 2007
- Efficacy of an Acellular Pertussis Vaccine among Adolescents and AdultsNew England Journal of Medicine, 2005
- Duration of Immunity Against Pertussis After Natural Infection or VaccinationThe Pediatric Infectious Disease Journal, 2005
- Societal Costs and Morbidity of Pertussis in Adolescents and AdultsClinical Infectious Diseases, 2004
- Adolescent and adult pertussis vaccination: computer simulations of five new strategiesVaccine, 2004